CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −7,155 | $60.36 | $432K | 95,316 |
| 2026-09-02 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −1,432 | $61.58 | $88K | 102,471 |
| 2026-08-31 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −1,273 | $60.74 | $77K | 103,903 |
| 2026-08-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +10,000 | $5.35 | $54K | 115,176 |
| 2026-08-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −6,956 | $53.76 | $374K | 108,220 |
| 2026-08-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −3,044 | $54.18 | $165K | 105,176 |
| 2026-08-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 216,827 | ||
| 2026-07-06 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +10,000 | $5.35 | $54K | 114,395 |
| 2026-07-06 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −7,913 | $57.16 | $452K | 106,482 |
| 2026-07-06 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −2,087 | $57.76 | $121K | 104,395 |
| 2026-07-06 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 226,827 | ||
| 2026-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +10,000 | $5.35 | $54K | 114,395 |
| 2026-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −10,000 | $53.00 | $530K | 104,395 |
| 2026-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 236,827 | ||
| 2026-03-09 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −1,021 | $59.32 | $61K | 104,395 |
| 2026-03-02 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −1,009 | $61.98 | $63K | 105,416 |
| 2026-02-28 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −898 | $61.98 | $56K | 106,425 |
| 2026-02-26 | GUGGENHIME ANDREW PRESIDENT AND CFO | Grant or award | +44,864 | 107,323 | ||
| 2026-02-26 | GUGGENHIME ANDREW PRESIDENT AND CFO | Grant or award · Stock Option (right to buy) | +74,993 | 74,993 | ||
| 2026-01-14 | GUGGENHIME ANDREW PRESIDENT AND CFO | Gift | −61,850 | 62,459 |
Page 1 of 9 · 173 trades